We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.38%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGACW
226
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$360 ﹤0.01%
60,000
CPARW
227
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$256 ﹤0.01%
150,780
ADBE icon
228
Adobe
ADBE
$109B
-694,772
Closed -$191M
CRBU icon
229
Caribou Biosciences
CRBU
$178M
-896,369
Closed -$9.46M
GRND icon
230
Grindr
GRND
$2.7B
-1,080,000
Closed -$11.2M
IBB icon
231
PUT
iShares Biotechnology ETF
IBB
$10.7B
-1,700,000
Closed -$199M
LH icon
232
Labcorp
LH
$27.3B
-250,625
Closed -$44.1M
META icon
233
Meta Platforms (Facebook)
META
$1.4T
-1,807,040
Closed -$245M
RC
234
Ready Capital
RC
$311M
-472,537
Closed -$4.79M
SONDW
235
DELISTED
Sonder Holdings Inc Warrants
SONDW
-150,000
Closed -$24K
TGNA
236
DELISTED
TEGNA Inc
TGNA
-825,000
Closed -$17.1M
VTYX
237
DELISTED
Ventyx Biosciences
VTYX
-70,000
Closed -$2.44M
CTLT
238
DELISTED
CATALENT, INC.
CTLT
-465,755
Closed -$33.7M
EXAI
239
DELISTED
Exscientia Plc American Depositary Shares
EXAI
-400,000
Closed -$3.28M
LLAP.WS
240
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
-239,233
Closed -$49K
SEPA
241
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
-1,732,500
Closed -$17.3M
GETR
242
DELISTED
Getaround, Inc.
GETR
-882,647
Closed -$8.69M
LCA
243
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
-802,028
Closed -$7.88M
SLAC
244
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
-750,000
Closed -$7.37M
THRX
245
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-223,149
Closed -$1.29M
TBCP
246
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
-1,208,326
Closed -$11.9M
GROV.WS
247
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
-200,000
Closed -$51K
AUY
248
DELISTED
Yamana Gold, Inc.
AUY
-3,900,000
Closed -$17.7M
IMGO
249
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
-2,471,313
Closed -$37.2M
GIIX
250
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
-692,810
Closed -$6.84M

Similar funds

Thomas Steyer's Q4 2022 Portfolio in Review

As of Q4 2022, Thomas Steyer held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Thomas Steyer withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Intuit worth $351M.

  • Thomas Steyer's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Thomas Steyer added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Thomas Steyer's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Thomas Steyer fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Thomas Steyer's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Thomas Steyer opened 13 new positions and closed 80 in Q4 2022.
  • Thomas Steyer's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.